[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100579177":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":22,"responsibleParty":35,"collaborators":10,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":40,"sex":46,"minAge":47,"maxAge":10,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":58,"overallStatus":64,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Charles University, Czech Republic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"critically ill patients",null,"critically ill patients admitted to ICU between 01.01.2020 and 31.12.2024",[13],{"name":14,"affiliation":15,"role":16},"Thomas Karvunidis, MD, PhD","Faculty of Medicine and Teaching Hospital, Charles University, Pilsen, Czech Republic","PRINCIPAL_INVESTIGATOR",[18],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},"CONTACT","+420776160620","karvunidist@fnplzen.cz",[23],{"facility":24,"status":10,"city":25,"state":26,"zip":27,"country":28,"countryCode":10,"cosmosGeoPoint":29,"geoPoint":34,"contacts":10},"Faculty of Medicine and Teaching Hospital, Charles University","Pilsen","Czech Republic","30460","Czechia",{"type":30,"coordinates":31},"Point",[32,33],13.37759,49.74747,{"lat":33,"lon":32},{"type":16,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Thomas Karvunidis","Principal investigator","100579177","hyperinflammation-and-hyperferritinemia-in-critically-ill-patients-100579177",false,"NCT06820905","Hyperinflammation and Hyperferritinemia in Critically Ill Patients","Hyperinflammation and Hyperferritinemia in Critically Ill Patients: a Retrospective Observational Single-center Analysis","HYFER","Inclusion Criteria:\n\n* critically ill patients\n* admission between 01.01.2020 and 31.12.2024 (5yrs)\n\nExclusion Criteria:\n\n* none","ALL","18 Years",{"count":49,"type":50},1962,"ESTIMATED","OBSERVATIONAL","Analysing trajectory of critically ill patients with signs of hyperinflammation",[54,55,56,57],"Critical Illness","Sepsis","Hyperferritinemia","Hyperinflammatory Syndrome",[59,60,61,62,63],"criticall illness","sepsis","ferritin","hyperinflammatory syndrome","sepsis phenotype","NOT_YET_RECRUITING","2025-02-06",{"date":67,"type":68},"2025-02-11","ACTUAL",{"date":70,"type":50},"2025-02-20",{"date":72,"type":50},"2025-11-30",{"name":5,"class":6},1]